Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Expected to Announce Earnings of $0.20 Per Share

Diabetes Tips, News & Articles

Equities research analysts forecast that Tandem Diabetes Care, Inc. (NASDAQ:TNDM) will announce earnings per share (EPS) of $0.20 for the current ...
Equities research analysts forecast that Tandem Diabetes Care, Inc. (NASDAQ:TNDM) will announce earnings per share (EPS) of $0.20 for the current ...
Read more
Note: This news content is auto-generated from a syndicated feed.

If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online

Popular posts from this blog

How the timing of dinner and genetics affect individuals' blood sugar control - ScienceDaily

Diabetes Tips, News & Articles Connections among food intake, melatonin levels and genetics may be important for diabetes risk. Date: January 25, 2022; Source: Massachusetts General ... Connections among food intake, melatonin levels and genetics may be important for diabetes risk. Date: January 25, 2022; Source: Massachusetts General ... Read more Note: This news content is auto-generated from a syndicated feed. If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online
Read more

Coronapod: COVID and diabetes, what the science says - Nature

Diabetes Tips, News & Articles According to a massive study, even mild COVID can significantly increase the risk of developing type 2 diabetes. According to a massive study, even mild COVID can significantly increase the risk of developing type 2 diabetes . Read more Note: This news content is auto-generated from a syndicated feed. If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online
Read more

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating ...

Diabetes Tips, News & Articles XW014 is an orally bioavailable small molecule GLP-1 receptor agonist in development for the treatment of obesity and type 2 diabetes. As a small ... XW014 is an orally bioavailable small molecule GLP-1 receptor agonist in development for the treatment of obesity and type 2 diabetes . As a small ... Read more Note: This news content is auto-generated from a syndicated feed. If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online
Read more